Nomura, Masashi https://orcid.org/0000-0001-6095-7849
Spitzer, Avishay
Johnson, Kevin C. https://orcid.org/0000-0003-0016-5158
Garofano, Luciano https://orcid.org/0000-0001-8582-0865
Nehar-belaid, Djamel https://orcid.org/0000-0001-6002-5021
Galili Darnell, Noam https://orcid.org/0009-0008-7624-0250
Greenwald, Alissa C.
Bussema, Lillian https://orcid.org/0000-0001-5469-3816
Oh, Young Taek
Varn, Frederick S. https://orcid.org/0000-0001-6307-016X
D’Angelo, Fulvio https://orcid.org/0000-0002-4940-4693
Gritsch, Simon
Anderson, Kevin J. https://orcid.org/0000-0002-2362-273X
Migliozzi, Simona
Gonzalez Castro, L. Nicolas https://orcid.org/0000-0001-7699-5188
ChowdhFury, Tamrin
Robine, Nicolas https://orcid.org/0000-0001-5698-8183
Reeves, Catherine https://orcid.org/0000-0002-9942-8909
Park, Jong Bae https://orcid.org/0000-0003-0207-0697
Lipsa, Anuja https://orcid.org/0000-0002-9668-6048
Hertel, Frank
Golebiewska, Anna https://orcid.org/0000-0002-4160-2521
Niclou, Simone P. https://orcid.org/0000-0002-3417-9534
Nusrat, Labeeba
Kellet, Sorcha
Das, Sunit
Moon, Hyo Eun
Paek, Sun Ha https://orcid.org/0000-0003-3007-8653
Bielle, Franck https://orcid.org/0000-0001-6564-6388
Laurenge, Alice https://orcid.org/0000-0002-0058-3176
Di Stefano, Anna Luisa https://orcid.org/0000-0003-1746-0647
Mathon, Bertrand https://orcid.org/0000-0002-9182-5846
Picca, Alberto
Sanson, Marc
Tanaka, Shota
Saito, Nobuhito
Ashley, David M. https://orcid.org/0000-0002-4754-5900
Keir, Stephen T.
Ligon, Keith L. https://orcid.org/0000-0002-7733-600X
Huse, Jason T. https://orcid.org/0000-0003-4514-0640
Yung, W. K. Alfred https://orcid.org/0000-0002-1669-0793
Lasorella, Anna https://orcid.org/0000-0002-1839-5421
Verhaak, Roel G. W. https://orcid.org/0000-0003-2773-0436
Iavarone, Antonio https://orcid.org/0000-0002-0683-4634
Suvà, Mario L. https://orcid.org/0000-0001-9898-5351
Tirosh, Itay https://orcid.org/0000-0001-5477-2987
Article History
Received: 5 April 2024
Accepted: 17 March 2025
First Online: 9 May 2025
Competing interests
: M.L.S. is equity holder, scientific cofounder and advisory board member of Immunitas Therapeutics. I.T. is advisory board member of Immunitas Therapeutics and scientific cofounder of Cellyrix. R.G.W.V. is a cofounder and equity holder of Boundless Bio. The authors declare that such activities have no relationship to the present study. The other authors declare no competing interests.